Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission

Inclusion Criteria:

* Aged 21-80;
* Cancer diagnosis ≤ 5 years;
* Received treatment with no current evidence of recurrence, with predicted life expectancy of 12 months and above;
* On regular follow-up with lab tests scheduled every 1-9 months;
* Recent (\<=3 months) blood test report(s) available on first study visit
* Diagnosed with the TCM syndrome of Qi deficiency and Blood stasis by the primary physician: experience 2 major symptoms coupled with typical tongue and pulse conditions; 2 major symptoms and 1 possible symptom coupled with tongue and pulse conditions; and 1 major symptom and at least 2 possible symptoms coupled with tongue and pulse conditions;

Exclusion Criteria:

* On active cancer treatment such as IV chemotherapy or radiotherapy or oral targeted therapy (excluding HRT and oral chemotherapy);
* Scheduled for IV chemotherapy, radiotherapy or surgery within the next 1 year from recruitment date;
* Diagnosed with active disease of the liver, kidney, brain, blood, blood vessels; with mental health conditions or are mentally incapacitated;
* Pregnant women.